Perspectives on the Management of Plaque Psoriasis

home / around-the-practice / perspectives-on-the-management-of-plaque-psoriasis

Expert panelists provide an overview of diagnosing and treating plaque psoriasis, addressing specific challenges in patient management.

EP. 1: Pathophysiology of Plaque Psoriasis and Targeted Therapies

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Helen Torok, MD;Jashin Wu, MD

December 16th 2021

A panel of experts review the nature of plaque psoriasis and the mechanism of action of several classes of targeted therapy.

EP. 2: Identifying Clinical Manifestations of Plaque Psoriasis

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

December 16th 2021

Shared insight on identifying clinical manifestations of plaque psoriasis and making a timely diagnosis.

EP. 3: Challenges in Diagnosing Plaque Psoriasis

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

December 23rd 2021

Panelists look deeper into the possible challenges or barriers to making an accurate diagnosis of plaque psoriasis

EP. 4: Understanding the Psychosocial Burden of Plaque Psoriasis

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

December 23rd 2021

Considerations for the psychological and social impact that plaque psoriasis may have on a patient.

EP. 5: Plaque Psoriasis Case 1: Patient Counseling and Approaching Therapy

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

January 5th 2022

Centering discussion on a case of plaque psoriasis, experts share their experience with patient counseling and selecting therapy.

EP. 6: Plaque Psoriasis Case 1: Selecting a Therapeutic Class

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

January 5th 2022

The panel reviews therapeutic classes and their respective benefits in patients being treated for plaque psoriasis.

EP. 7: Moderate to Severe Plaque Psoriasis: What is the Standard of Care?

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

January 10th 2022

Taking a broader look at moderate to severe plaque psoriasis, experts consider what the standard of care would be in different settings.

EP. 8: Moderate to Severe Plaque Psoriasis: An Overview of Biologic Agents

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

January 10th 2022

A brief review of biologic agents being used or evaluated in the setting of plaque psoriasis.

EP. 9: Bimekizumab’s Potential in Moderate-to-Severe Plaque Psoriasis

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

January 17th 2022

A focused discussion on the benefit of bimekizumab, an IL-17A/IL-17F inhibitor, in the setting of moderate to severe plaque psoriasis.

EP. 10: Plaque Psoriasis: Biologic Therapy Toxicity Profiles

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

January 17th 2022

A panel of experts reflect on the toxicity profiles of biologic agents used to treat patients with plaque psoriasis.

EP. 11: Factors in Selecting Biologic Therapy for Moderate to Severe Plaque Psoriasis

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

January 24th 2022

Panelists share which factors they use to determine optimal therapy in the moderate to severe plaque psoriasis setting.

EP. 12: Plaque Psoriasis Patient Case 2: Switching Therapy at Treatment Failure

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

January 24th 2022

Moving on to the second patient case, panelists discuss switching therapy at treatment failure for plaque psoriasis.

EP. 13: Plaque Psoriasis Patient Case 2: Factors in Selecting 2L Therapy

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

January 31st 2022

Shared insight on which factors are most important in determining second-line therapy for plaque psoriasis.

EP. 14: Unmet Needs in Moderate to Severe Plaque Psoriasis Management

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

January 31st 2022

A brief discussion on the unmet needs and ongoing challenges in the treatment of plaque psoriasis.

EP. 15: Biologic Therapy in Plaque Psoriasis: Treating During the COVID-19 Pandemic

Christopher G. Bunick, MD, PhD;Mark G. Lebwohl, MD;Jashin Wu, MD;Helen Torok, MD

February 7th 2022

Experts reflect on the treatment of patients with plaque psoriasis during the COVID-19 pandemic.

EP. 16: Plaque Psoriasis Management: Future Directions in Care

Christopher G. Bunick, MD, PhD;Helen Torok, MD;Mark G. Lebwohl, MD;Jashin Wu, MD

February 7th 2022

Closing out their discussion on the management of plaque psoriasis, panelists share their excitement for future directions in care.

Advertise

Job Board

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777